The 60,000-square-foot medtech office building is an early step in Destination Medical Center effort.
The implantable device is backed by Italy’s Sorin Group and venture capital investors.
It was part of a $12 million Series A round led by Johnson & Johnson Innovation.
Rion LLC is developing tissue-growing biotech for cardiac, wound care markets.
2bPrecise LLC will use know-how in platform to fight familial hypercholesterolemia.
Funding pitched as key to school’s growing undergrad biology program.
Soundly touts airway-strengthening therapy as alternative to burdensome CPAP masks.
MnDRIVE snags funds for cancer research as sun sets on program to help startups.
MRI Interventions has development deal with clinic for new stroke therapies.
Move is part of new collaboration to develop system for treating arrhythmia.
Milken Institute report sites strength in income-generating licenses.
Backing comes from Canadian company in medical cannabis market.
Medtech’s move follows hires of locally based CEO and CFO.
Participates in $50M round for Magenta Therapeutics, forges strategic partnership.
Waterline Ventures, Bluestem Capital invest in patient care monitoring console.
Life sciences experts Hackett, Elias among school’s Innovation Award winners.
Roster includes researchers whose projects have commercialization potential.
Award comes as his Rochester startup sees demand spike for its patented tech.
Mayo-backed viral oncology firm graduating from clinic’s biz incubator.
Timing to take advantage of pending FDA ban on partially hydrogenated oils.
The two Minn. institutions combined for more than $500M in NIH funding last year.
Five life sciences research projects nearing market stage land MN-REACH funding.
Patent application filed on antibody used for individualized cancer treatments.
Health IT startup has $3.9M of total already in hand, SEC filing indicates.
Heart signal-processing firm teams with clinic on a 10-year collaboration.
Hennepin County researchers are advancing work that could help end the United State's burgeoning painkiller problem.
Bigger stake in AliveCor comes as firm rolls out expansion of detection software.
Proposal would make angel credit permanent and boost annual funding to $20 million.
Inventors said the new test can quickly determine if leukemia treatments are working.
Med device firm must meet shareholder’s equity requirements by March 20.
New East Bank building seeks to align curriculum with changing healthcare market.
It would allow therapies to bypass ‘blood-brain barrier’ to treat neuro conditions.
The Brothers Snyder laud hometown’s buzzing bio-business startup scene.
Startup Medicool targets irregular heartbeat with $250K NSF seed funding.
New drug candidate is latest tack in addressing hospital-acquired infections.
Detecting cancerous tumors from blood samples is the goal of Illumina and Exact Sciences.
StemoniX, Gila Therapeutics, MicroOptx lead pack in DEED’s annual accounting.
Xcede Technologies is ready to test a hemostatic patch for severe bleeding.
DayTwo’s individualized diet technology uses algorithm to predict glucose levels.
School commits $2.5M to navigate market path for BHB/M after 2010 startup bust.
New unit will provide corporate, government partners with simplified path.
The company was tapped to play key role in Kite Pharma’s promising T-cell lymphoma candidate.
The team behind Cologuard is working to extend methods to more gastrointestinal cancers.
Initial client list includes Ridgeview Medical, Centra Health, and Medcan.
Brian Bischoff is working with UMN professors to unlock stem cell blood supply promise.
Backers say wet lab conversion could tap buzzing Southeast Minnesota startup scene.
Provides web-based tool to help hospitals reduce ‘adverse events.'
Jacksonville team’s latest describes drug treatment for frontotemporal dementia.
They say benefits from sequencing genomes can’t be widely applied without changes.
Based on Mayo ‘cell senescence’ research, San Francisco-based Unity Biotechnology rakes in $116 million financing.
Patent filed for ‘smart’ polymer that could have big implications for pharma pipelines.
Deal includes investment in Silicon Valley digital health start-up AliveCor.
Leaders discuss how they approach high-growth overseas markets for devices.
Leaders of Twin Cities’ CRVx, Rotation Medical talk strategy in a tough capital climate.
State-funded program focuses on biotech, other fields with commercialization promise.
Calyxt founder Dan Voytas is applying editing methods for non-GMO crop improvements.
Same lab recently announced a breakthrough in mouse modeling for ALS research.
MN-REACH grant moves cellular-level tumor probe closer to market.
Colorectal cancer test’s epic journey to market a case study for innovation.
Close ties cited between Chrono Therapeutics, Mayo’s Nicotine Dependence Center.
A focus on technology transfer at Mayo’s Transform 2016 conference.
Top researchers James Russell, Moses Rodriguez cited as inventors of virus tech platforms.
University, Fate Therapeutics on commercialization track for cutting-edge immunotherapy.
Anthony Cataldo of Oxis Biotech touts immunotherapies targeting lymphoma and leukemia.
Evelo Biosciences joins four others as investment, research dollars flow into field.
Diagnostic kit-maker DiaSorin tapped by U.S. to roll out test, process results.
After launch of Unity Biotechnology, study links osteoarthritis to ‘senescent’ cells.
With ties to U of M and Mayo Clinic, the start-up seeks to build on state’s genomics expertise.
Assurex Health’s licensed tech taps fast-growing neuroscience genomics market.
Shoreview firm to ramp up availability of magnetic “sphincter” devices as insurers sign on.
LAgen Laboratories produces bioengineered retinal cells for pharma, others.
Unequal medical outcomes, treatment resulting in trillions of dollars in extra costs.
A new round of state grants recognize promising bio-businesses in an exploding industry.
A look at MN-REACH grant winners can provide some future market insight.
As early trials show promise, ‘serial biotech entrepreneur’ Steve Gorlin signs on.
Inventors include founders of Minnesota start-ups Zumbro Discovery and NeoChord.
Celyad will accelerate commercialization of the C-Cure stem cell therapy after Phase III results.
IRRRB grants $38,000 to BRTI and the Northshore Business Enterprise Center.
Blueprint Bio’s biomarker discovery platform taps personalized medicine momentum.
Florida-based TapImmune exercises option, readies Phase II trials for HER2/neu cancer immunotherapy platform.
A look at the Rochester clinic’s Top 10 National Institutes of Health awards.
Regenerative, individualized medicine researchers seem likely picks for new Rochester buildings.
The company has thus far eschewed venture capital.
The clinic was an early investor in the company.
The latest and most innovative patents coming out of the Rochester medical powerhouse.
Mayo Clinic is at the forefront of integrating medicine outside the physician’s office into the organization.
The tissue regeneration company is preparing for human testing.
The health care provider has a joint venture with Cancer Genetics Inc. that will roll out a genetic sequencing test to better personalize cancer treatment.
Exact Sciences is already using Mayo research to roll out an at-home colorectal cancer screening kit.
The company likes the control it maintains by soliciting investment from within.
The next frontier of cancer treatment could be vaccines.
Can the bacteria living inside provide untapped health benefits?
Researchers will scan football players’ brains to determine if a supplemental vitamin can boost enzymes in the brain.
Two DFLers propose spending millions to help the state compete with the likes of California and Massachusetts.
Magnetic resonance elastography (MRE) is proving better at diagnosing cases of nonalcoholic fatty liver disease.
The DMC project is expected to create 45,000 jobs. But where will they come from, and is there any place for them to live?
A collaboration between Mayo and HART is attempting to introduce a bioengineered organ implant system into the market.
The med-tech startup is testing a new platform for treating complex heart arrhythmia.
Industry insiders say the collaboration was made possible in part through the repeal of the medical device tax.
An experimental drug tested by the medical organization appears to inhibit a key enzyme within cancerous cells.
Researchers are hopeful that smaller, more efficient machines will aid in studying brain disorders and issues.
Ambient Clinical Analytics software going global in Philips’ patient monitoring devices.
Why technology previously transferred outside Minnesota is now more likely to remain in Rochester.
Costs of wind and solar energy have dropped, making renewable energy a viable option for many businesses.
Despite many critics, tax-increment financing districts are on the rise in Minnesota.
Anyone who feels their neighborhood lacks, say, a bakery, can post the idea on the website.
Town Hall Tap owners chose to build the restaurant at 48th and Chicago rather than in Northeast Minneapolis partly because of the looser 60/40 food-alcohol-sales ratio.